Skip to content

Author

Feng-Xiang Zhang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Efficacy of prolonged adjuvant imatinib in gastrointestinal stromal tumors: a systematic review and exploratory network meta-analysis

Three years of adjuvant imatinib is the established standard for patients with high-risk gastrointestinal stromal tumors (GIST), but recurrence after treatment cessation raises questions about longer treatment durations. This study evaluated evidence on extended adjuvant therapy, emphasizing treatment beyond 3 ye...

Feng-Xiang Zhang, Ze-Qun Chen, Zhou-Sheng Su et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.